CYRX News and Press, CryoPort Inc. From 11/08/23

2023-11-08 04:55:00 ET Summary Headwaters Capital Management is an actively managed, concentrated investment strategy focused on small and mid-capitalization stocks. Headwaters Capital Management's portfolio declined by 7.6% in Q3 2023, compared to a 4.7% return for the Russell Mi...

CryoPort Inc. (CYRX) is expected to report $-0.31 for Q3 2023

Cryoport Continues its Expansion in the European Market with Tec4med Lifescience GmbH Acquisition PR Newswire Strategic Acquisition Strengthens Condition Monitoring Systems and Logistics Management Capabilities for the Biopharmaceutical Industry Throughout Cryoport's Family of...

Cryoport to Report Third Quarter 2023 Financial Results on November 8, 2023 PR Newswire NASHVILLE, Tenn. , Oct. 25, 2023 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and serv...

2023-10-12 09:06:35 ET More on CryoPort Cryoport to establish first U.K. logistics center Morgan Stanley starts Cryoport at equal weight, cites attractive fundamentals For further details see: Cryoport inks new multi-year supply chain solutions agreement with Mon...

Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVF PR Newswire NASHVILLE, Tenn. , Oct. 12, 2023 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and se...

2023-10-10 12:39:59 ET More on CryoPort Cryoport: Great Potential That Management Continues To Fail To Actualize Cryoport, Inc. (CYRX) Q2 2023 Earnings Call Transcript Cryoport: Revising To Hold After Major Changes To Forecasts, Sentiment Morgan Stanley start...

Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies PR Newswire Partnership Establishes Cryoport Systems' First U.K. Logistics Center to Support Future Expansion ...

Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies PR Newswire Partnership will provide access to standardized and optimized apheresis collection, cryopreservation and bioprocessing processes throughout the U.S. and ...

2023-10-03 09:39:55 ET Summary Cryoport has experienced a decline in revenue and worsening bottom line results over the past year. The company's stock has fallen 30.6% since May and 64.2% since July 2022. Despite potential in the life sciences market, Cryoport needs to show pr...